Atrial Fibrillation Ablation Using PENTARAY CatheterNCT05101980
Predictors of Atrial Fibrillation Recurrence After Ablation Using PENTARAY Catheter
An observational study of Atrial Fibrillation Ablation Using PENTARAY Catheter, run by Assiut University.
Trial summary
CARTO represent a new way of 3D electroanaromic mapping for AF which has improved safety and success rate of AF ablation compared with other conventional methods of AF ablation as it provide accurate visualization of atrial anatomy and identification of atrial substrate properties for catheter ablation of atrial… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Atrial Fibrillation Ablation Using PENTARAY Catheter
- How many people
- 20 participants
- Where
- No sites listed yet
- Study dates
- 1 Dec 2021to 30 Mar 2024
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients with paroxismal AF who are eligible for AF ablation
Who may be able to join
- Patient with paroxismal AF who are eligible for AF ablation
- Patient resistant to medical treatment
Who cannot join
- Patient with other types of arrythmias
- Patient with prothetic valves
- Patient with valvular AF
About this study
CARTO represent a new way of 3D electroanaromic mapping for AF which has improved safety and success rate of AF ablation compared with other conventional methods of AF ablation as it provide accurate visualization of atrial anatomy and identification of atrial substrate properties for catheter ablation of atrial arrythmias which ensure good ablation with decreased incidence of recurrence of AF.
What is being measured
The primary outcome is the main question the study is designed to answer.
Maintenance of sinus rhythm after successful ablation of atrial fibrillation
Measured: 6 months after AF ablation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Nov 2021
- Study start1 Dec 2021 (estimated)
- Primary completion30 Dec 2023 (estimated)
- Study completion30 Mar 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Atrial Fibrillation Ablation Using PENTARAY CatheterStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Maria Hamdy Bassit, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05101980
- Sponsor's protocol ID
- PENTARAY catheter
- Status last verified
- Nov 2021
- First submitted
- 20 Oct 2021
- Last updated
- 29 Nov 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No